跳至主要内容
临床试验/JPRN-UMIN000003006
JPRN-UMIN000003006已完成4 期

Prospective, randomized, open-label, clinical trial comparing the different Sufonyl Urea(SU) combination with DPP4 inhibitor - Prospective, randomized, open-label, clinical trial comparing the different Sufonyl Urea(SU) combination with DPP4 inhibitor

Kobe University Hospital0 个研究点目标入组 80 人开始时间: 2010年1月9日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.History of hypersensitivity to sulfonyl urea or sitagliptin 2.During the pregnancy and nursing 3. Severe renal dysfunction (serum creatinin>2.0mg/dl) 4. Severe liver dysfunction (AST, ALT>50IU/ml) 5. 6.Inadequate to entry this study

研究者

相似试验

已完成
4 期
Prospective, randomized, open-label, clinical trial comparing fibrate monotherapy and fibrate-ezetimibe combination therapy on progression of atherosclerotic plaques, endothelial function, and markers for anti-inflammatory properties/obesity/antioxidative propertiesdyslipidemia
JPRN-UMIN000002964ational Defense Medical College60
招募中
不适用
Prospective, randomized, open-label, clinical trial comparing the effects of hydrogen tablet and placebo on blood pressure, endothelial function and makers for cardiovascular diseasesHypertension
JPRN-UMIN000021154Tokorozawa Heart Center34
已完成
不适用
Prospective, randomized, open-label, clinical trial comparing the effects of statin monotherapy and statin-ezetimibe combination therapy on progression of atherosclerotic plaques, endothelial function, markers for anti-inflammatory properties/obesity/antioxidative propertiesCoronary artery diseases
JPRN-UMIN000002960ational Defense Medical College60
招募中
不适用
Prospective, randomized, open-label, clinical trial comparing the effects of topiroxostat and febuxostat on serum uric acid, endothelial function and markers for kidney injury
JPRN-UMIN000026765Tokorozawa Heart Center33
已完成
不适用
Prospective, randomized, open-label, clinical trial comparing the effects of losartan (regular dose) /hydrochlorothiazide combination and losartan alone (high-dose) on blood pressure, endothelial function and markers for obesity/oxidative stress/chronic kidney diseasesHypertension
JPRN-UMIN000002961ational Defense Medical College30